Companies / Globus Medical Inc / Activity
Activity — Globus Medical Inc
30 moves.
Top impactInsider · CEO movesInsider · biggest buysInsider · biggest sellsInstitution · biggest movesInstitution · new positions
| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Jun 5, 2026 | Davidar David D Director | Sell | Class A Common Stock | $2.02M | -25K -4.67% | 510,175 0.38% of shares | medium |
| Feb 25, 2026 | Huller Kelly Executive | Sell | Class A Common Stock | $1.89M | -20K -100.00% | 0 0.00% of shares | medium |
| Feb 12, 2026 | Huller Kelly Executive | Sell | Class A Common Stock | $876.7K | -10K -100.00% | 0 0.00% of shares | medium |
| Feb 25, 2026 | Huller Kelly Executive | Exercise | Class A Common Stock | $871.6K | +20K | 20,000 0.01% of shares | low |
| Jun 5, 2026 | Davidar David D Director | Exercise | Class A Common Stock | $656.8K | +25K +4.90% | 535,175 0.40% of shares | low |
| Jun 4, 2026 | Rhoads Ann D Director | Exercise | Class A Common Stock | $656.8K | +25K +162.51% | 40,384 0.03% of shares | low |
| Feb 12, 2026 | Huller Kelly Executive | Exercise | Class A Common Stock | $456.4K | +10K | 10,000 <0.01% of shares | low |
| Jan 8, 2026 | Kline Kyle Executive | Sell | Class A Common Stock | $363.4K | -4K -100.00% | 0 0.00% of shares | medium |
| Jan 8, 2026 | Norwalk Leslie V Director | Sell | Class A Common Stock | $202.2K | -2K -16.10% | 10,419 <0.01% of shares | medium |
| Jan 8, 2026 | Kline Kyle Executive | Exercise | Class A Common Stock | $186.4K | +4K | 3,594 <0.01% of shares | low |
| Jan 2, 2025 | Davidar David D Director | Gift | Class A Common Stock | $0 | -6K -1.18% | 510,175 0.38% of shares | low |
| Jun 5, 2026 | Davidar David D Director | Exercise | Stock Option (Right to Buy Class A Common Stock) | — | -25K -100.00% | 0 0.00% of shares | low |
| Jun 4, 2026 | Rhoads Ann D Director | Exercise | Stock Option (Right to Buy Class A Common Stock) | — | -25K -100.00% | 0 0.00% of shares | low |
| Feb 25, 2026 | Huller Kelly Executive | Exercise | Stock Option (Right to Buy Class A Common Stock) | — | -20K -50.00% | 20,000 0.01% of shares | low |
| Feb 12, 2026 | Huller Kelly Executive | Exercise | Stock Option (Right to Buy Class A Common Stock) | — | -10K -100.00% | 0 0.00% of shares | low |
| Jan 21, 2026 | Huller Kelly Executive | Grant | Stock Option (Right to Buy Class A Common Stock) | — | +40K | 40,000 0.03% of shares | low |
| Jan 21, 2026 | Pfeil Keith W CEO | Grant | Stock Option (Right to Buy Class A Common Stock) | — | +100K | 100,000 0.07% of shares | low |
| Jan 21, 2026 | Wolterman Dan Director | Grant | Stock Option (Right to Buy Class A Common Stock) | — | +15K | 15,000 0.01% of shares | low |
| Jan 21, 2026 | Paul David C Executive | Grant | Stock Option (Right to Buy Class A Common Stock) | — | +100K | 100,000 0.07% of shares | low |
| Jan 21, 2026 | Davidar David D Director | Grant | Stock Option (Right to Buy Class A Common Stock) | — | +15K | 15,000 0.01% of shares | low |
| Jan 21, 2026 | Norwalk Leslie V Director | Grant | Stock Option (Right to Buy Class A Common Stock) | — | +15K | 15,000 0.01% of shares | low |
| Jan 21, 2026 | Lemaitre Dan Director | Grant | Stock Option (Right to Buy Class A Common Stock) | — | +15K | 15,000 0.01% of shares | low |
| Jan 21, 2026 | DeFord John A Director | Grant | Stock Option (Right to Buy Class A Common Stock) | — | +15K | 15,000 0.01% of shares | low |
| Jan 21, 2026 | Douglas Robert Andrew Director | Grant | Stock Option (Right to Buy Class A Common Stock) | — | +15K | 15,000 0.01% of shares | low |
| Jan 21, 2026 | Rhoads Ann D Director | Grant | Stock Option (Right to Buy Class A Common Stock) | — | +15K | 15,000 0.01% of shares | low |
| Jan 21, 2026 | Kline Kyle Executive | Grant | Stock Option (Right to Buy Class A Common Stock) | — | +30K | 30,000 0.02% of shares | low |
| Jan 21, 2026 | Tobin James R Director | Grant | Stock Option (Right to Buy Class A Common Stock) | — | +15K | 15,000 0.01% of shares | low |
| Jan 21, 2026 | Zarrilli Stephen T Director | Grant | Stock Option (Right to Buy Class A Common Stock) | — | +15K | 15,000 0.01% of shares | low |
| Jan 8, 2026 | Kline Kyle Executive | Exercise | Stock Option (Right to Buy Class A Common Stock) | — | -4K -47.92% | 3,906 <0.01% of shares | low |
| Dec 1, 2025 | Kline Kyle Executive | Exercise | Stock Option (Right to Buy Class A Common Stock) | — | -5K -97.92% | 104 <0.01% of shares | low |